McKesson Ventures
VC Fund
San Francisco, United States
McKesson Ventures is a VC fund in San Francisco focused on Health Care and Information Technology. McKesson Ventures they help entrepreneurs in healthcare technology and services to create efficient health care delivery systems for key stakeholders on all sides of the health care economy.
- Total investments:
- 61
- Last investment:
- Lead investor:
- 31%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries McKesson Ventures invests in
Stages McKesson Ventures invests in
Countries McKesson Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Investment Focus
Industry
- Health Care 39 (64%)
- Information Technology 15 (25%)
- Medical 14 (23%)
- Software 12 (20%)
- Hospital 8 (13%)
Stage
- Series B 15 (25%)
- Series A 11 (18%)
- Series C 9 (15%)
- Private Equity 5 (8%)
- Series D 4 (7%)
Country
- United States 43 (70%)
- Canada 1 (2%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Carrie Williams
Vice President and Partner
|
Vice President and Partner | Total investments: 7 | Find email | |
Dave Schulte
SVP, Managing Director
|
SVP, Managing Director | Total investments: 17 | Find email | |
Ed Albrektsen
Director, Vendor Solutions & Audit
|
Director, Vendor Solutions & Audit | Total investments: 0 | Find email | |
Jennifer Carter
Vice President, Portfolio Development; Partner & Vice President Venture Operations
|
Vice President, Portfolio Development; Partner & Vice President Venture Operations | Total investments: 0 | Find email | |
Michelle Snyder
Partner
|
Partner | Total investments: 2 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BranchLab makes healthcare advertising better so that people may find the best healthcare options. | $28.8M / Series A / May 13, 2026 | ||
| Latent is a creator of medical language models aimed at reducing healthcare operational costs. | $80M / Series A / Mar 18, 2026 | ||
| Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $100M / Series D / Feb 03, 2026 | ||
| Prudentia Sciences is a platform enables AI-powered Asset Diligence and Valuation to De-Risk Investment in Drug Development. | $20M / Series A / Jan 07, 2026 | ||
| Oath Surgical is creating the surgical care of the future, one that is value-based by design, tech-powered, and led by surgeons. The first vertically integrated system that combines tech-first surgical centers with AI software. | $24M / Series A / Oct 06, 2025 | ||
| Lumata Health is a technology-driven healthcare startup focused on preventing blindness from chronic eye conditions, managing thousands of people at risk of vision loss across the United States. Founded in 2017 by an ophthalmologist and retina specialist in practice for over 30 years, Stephen R. Fransen, MD, and supported by more than 30 industryluminaries and influencers on its Advisory Board, Lumata Health aims to stop preventable blindness with a human-led, intelligent care coordination and management platform that’s almost always free to the patient. The company partners with physicians, payers and health systems to offer turnkey care management services provided by eye care experts who are supported by cutting edge technology and data science. Lumata Health’s programs improve clinical outcomes, patient satisfaction, and clinic staff efficiency by providing between-visit patient assistance and care coordination for patients with chronic eye diseases such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. | $23M / Series B / Mar 05, 2025 | ||
| Lynx is a fintech platform focused on healthcare, providing an API-connected service that enables businesses to incorporate payments, banking, and e-commerce seamlessly. Lynx FinHealth is a contemporary financial solution tailored to current healthcare demands, explicitly stating that it is not a bank. Instead, banking services and debit cards areoffered through partnering banks. | $27M / Series A / Feb 06, 2025 | ||
| Bluenote Health operates as an AI platform for life sciences. | $10M / Dec 20, 2024 | ||
| USMM is a family of companies dedicated to providing high-quality, coordinated healthcare in the home. USMM has also developed and owns several allied health assets, which assist in the provision of home-based primary care and furthers the value and efficiency of house call medicine. | $200M / Private Equity / Jul 08, 2024 | ||
| Atropos Health rapidly provides personalized real-world evidence for any clinical decision | $33M / Series B / May 23, 2024 | ||
| See all 61 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does McKesson Ventures invest in?
McKesson Ventures invests primarily in Health Care, Information Technology and Medical startups, most often at Series B and Series A stage. Most of the 61 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact McKesson Ventures?
Public channels for McKesson Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at McKesson Ventures?
The team at McKesson Ventures includes Carrie Williams (Vice President and Partner), Dave Schulte (SVP, Managing Director) and Ed Albrektsen (Director, Vendor Solutions & Audit), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
